Astria Therapeutics, Inc. Ratios

Ratios Dec2014 Dec2015 Dec2016 Dec2017 Dec2018
Profitability
EBT Margin 10,624.76%3,337.12%4,319.35%-5,479.20%26,046.00%
EBIT Margin 10,524.76%3,237.12%4,248.27%-5,418.80%26,371.00%
EBITDA Margin 10,524.76%3,237.12%4,248.27%-5,418.80%26,371.00%
Operating Margin 10,524.76%3,237.12%4,248.27%-5,418.80%26,371.00%
Net Margin 10,624.76%3,337.12%4,319.35%-5,479.20%26,046.00%
FCF Margin 10,019.42%3,089.37%3,980.53%-5,378.60%23,483.00%
Efficiency
Assets Average 28.53M
Equity Average 23.37M
Invested Capital 11.79M34.94M
Asset Utilization Ratio 0.00
Leverage & Solvency
Interest Coverage Ratio -105.25-32.37-42.48-58.65-263.71
Equity Ratio 0.660.89
Times Interest Earned -105.25-32.37-42.48-58.65-263.71
Valuation
Enterprise Value 121.31M67.33M18.02M-6.53M
Market Capitalization 121.31M67.33M34.39M31.04M
Return Ratios
Return on Sales 106.25%33.37%43.19%-54.79%260.46%
Return on Capital Employed -1.08%
Return on Assets -0.91%
Return on Equity -1.11%